85-4479-73 NKX3-1, Recombinant, Human, aa1-234, His-Tag (Homeobox protein Nkx-3.1) 500ug 350121
特徴
- NKX3-1 is a homeobox-containing transcription factor, which binds preferentially the consensus sequence 5'-TAAGT[AG]-3' and can behave as a transcriptional repressor. This transcription factor functions as a negative regulator of epithelial cell growth in prostate tissue. Aberrant expression of NKX3-1 is associated with prostate tumor progression. Alternate splicing results in multiple transcript variants of this.
- Source:Recombinant protein corresponding to aa1-234 of human NKX3-1, fused to His-tag at N-terminal expressed in E. coli.
- Molecular Weight:~28.7kD
- AA Sequence:MGSSHHHHHH SSGLVPRGSH MGSMLRVPEP RPGEAKAEGA APPTPSKPLT SFLIQDILRD GAQRQGGRTS SQRQRDPEPE PEPEPEGGRS RAGAQNDQLS TGPRAAPEEA ETLAETEPER HLGSYLLDSE NTSGALPRLP QTPKQPQKRS RAAFSHTQVI ELERKFSHQK YLSAPERAHL AKNLKLTETQ VKIWFQNRRY KTKRKQLSSE LGDLEKHSSL PALKEEAFSR ASLVSVYNSY PYYPYLYCVG SWSPAFW
- Storage and Stability:May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size:500ug
- Source Antigen:Recombinant, E. coli
- Grade:Purified
- Purity:~85% (SDS-PAGE)
- Form:Supplied as a liquid in 20mM Tris-HCl, pH 8.0, 2M urea, 10% glycerol.
- Molecular Weight Non Ab:28.7
- EU Commodity Code:30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-4479-72
NKX3-1, Recombinant, Human, aa1-234, His-Tag (Homeobox protein Nkx-3.1) 100ug
|
|
|
85-4479-73
NKX3-1, Recombinant, Human, aa1-234, His-Tag (Homeobox protein Nkx-3.1) 500ug
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





